Similarly, in a longitudinal cohort study of anti-NXP2 positive patients in the United States, only 7% of patients developed ILD with a reported mean FVC of 87%, unfortunately, this study did not discuss whether these patients underwent pulmonary imaging (59). Here, MORC3 is linked to interstitial lung disease.